A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study aims to evaluate the safety and tolerability of HRS-1893 in subjects with heart failure with preserved ejection fraction.
Epistemonikos ID: 9526cd11f52b2382ee42fb1986eca7fd9c7fbf3c
First added on: Dec 09, 2025